People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Summit Therapeutics Inc. | — | Biotechnology | Series D+ | $569.0M | $2.4B | 2024 |
| Aseko Inc. | — | Other Health Care | Series B | $75.9M | $211.2M | 2012 |
| Zoonie, LLC | — | Other Health Care | Series B | $52.0M | $708.1M | 2013 |
| Virobay Inc | — | Other Health Care | Series B | $28.3M | $398.8M | 2009 |
Robert Booth at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Booth on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Huber | 1 | 75 |
| Mostafa Ronaghi | 1 | 8 |
| David Wurzer | 1 | 7 |
| Heather Preston | 1 | 6 |
| Robert Fischell | 1 | 6 |
| Andrew Midler | 1 | 6 |
| Jeffrey Bird | 1 | 5 |
| Phillip D. Torrence | 1 | 4 |
| Cheryl Pegus | 1 | 4 |
| Thomas Dietz | 1 | 4 |
| Jim Mellon | 1 | 4 |
| Tim A Fischell | 1 | 4 |
| Raymond Spencer | 1 | 3 |
| Mahkam Zanganeh | 1 | 3 |
| Daniel Janney | 1 | 3 |
| Randall Hawkins | 1 | 3 |
| Scott Gottlieb | 1 | 3 |
| David Roblin | 1 | 3 |
| Robert Duggan | 1 | 3 |
| Kenneth Clark | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.